ISLAA Highlights 2016


Session 1 – Anatomy and Physiology

Anatomy of Left Atrial Appendage and its Relevance to Systemic Thromboembolism and Exclusion Approaches – Dr. Luigi Di Biase

Impact of Exclusion on Neurohormonal Modulation and Down Regulation of RAAS – Does LAA Exclusion Really Affect It? – Dr. Dhanunjaya Lakkireddy

LAA Role in Atrial Arrhythmias Origin and Maintenance – Dr. Andrea Natale

Panel Discussion

Session 2 – Amulet ACP Device

Construct of the ACP Amulet and Implantation Indication – Dr. Apostolos Tzikas

Recorded Case – Amulet Plug – Dr. Thorsten Lewalter

Managing Post Procedural Anticoagulation and Antiplatelet Treatment – Dr. Moussa Mansour

Understanding Leaks, Pulmonary Vein and Mitral Valve Impingement – Dr. Lars Sondergaard

Session 3 – Watchman Case 1

Understanding the Watchman Device and Implantation Tools – Dr. Shephal Doshi

Step by Step Approach – Pointers for Access/Navigation/Deployment/Confirmation – Dr. Saibal Kar

Live Case –Watchman – Dr. Vivek Reddy and Dr. Srinivas Dukkipati

Post Implant Anticoagulation and Imaging Protocols – Dr. Vijay Swarup

Post Watchman Leaks – Implications and Management – Dr. David R. Holmes, Jr.

Session 4 Lariat Case 1

Understanding the Lariat Device and Implantation Tools – Dr. Jie Cheng

Tips and Tricks for Safe Epicardial Access – Dr. Randall Lee

Tips and Tricks for Safe Transseptal Puncture and Device Manipulation – Dr. Christopher Ellis

Recorded Case – Lariat – Dr. Larry Chinitz

Percutaneous Left Atrial Appendage Closure with Lambre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study– Dr. He Huang

Managing Post Procedural Pericardial Drain and Pericarditis – Dr. Abdi Rasekh

Panel Discussion

Session 5 – Watchman Case 2

Who is the Right Candidate for Watchman LAA Occlusion – Warfarin Eligible and Warfarin Ineligible – Dr. Reda Ibrahim

Live Case – Watchman  – Dr. Vivek Reddy and Dr. Srinivas Dukkipati  

How to Fish an Embolized Device and Save the Day! – Dr. Jacqueline Saw

Managing Pericardial Effusions, Onsite Thrombus and Device Erosion in Watchman Cases – Dr. Moussa Mansour

Panel Discussion

Session 6 – Lariat Case 2

Who is an Appropriate Lariat Candidate? – Dr. Christopher Ellis

FDA Safety Alert and What Does that Mean to Clinical Practice? – Dr. Suneet Mittal

Recorded Case – Lariat – Dr. Abdi Rasekh

Implications and Management of Post Lariat Leak – Dr. Douglas Gibson

Lariat LAA Ligation in AF Treatment – LAALA AF, AMAZE and More – Dr. Dhanunjaya Lakkireddy

Dr. Lakkireddy Follow Up Questions

Panel Discussion

Session 7 LAA Exclusion and Imaging

Thrombus in the LAA – To Call it or Not to Call it? Tricks for Enhancing the Borderline Calls, False Positive and False Negatives TEE/CT/ICE– Dr. Jayant Nath

Pre and Intraprocedural TEE Imaging Tricks for Effective LAA Exclusion – Dr. Swaminatha Gurudevan

CT Imaging for LAA Exclusion – Pre and Post Procedural Assessment – Dr. Randall Lee

3 Dimensional Printing and its Use in LAA Exclusion – Dr. Horst Sievert

Session 8 AtriClip Device

Anatomy of AtriClip and Step by Step Implant Process – Dr. Sacha Salzberg

AtriClip Recorded Case – Dr. Basel Ramlawi

Post Procedural Management of AtriClip – Pericarditis/Anticoagulation/Imaging – Dr. James Edgerton

AtriClip – Robotic versus VATS versus Mini-Thoracotomy Approaches – Dr. Ali Khoynezhad

Panel Discussion

Session 9 Miscellaneous LAA Occlusion Devices

Lambre Device – Recorded Case and Current Data – Dr. Horst Sievert

Wave Crest Device – Recorded Case and Current Data – Dr. Saibal Kar

The Less Studied LAA Occlusion Devices – An Overview (Includes Aegis/Occlutech/Prolipsis/Cardia/Acoredis and More) – Dr. Shephal Doshi

Panel Discussion

Session 10 Show Me the Data

Watchman Trials Update – Dr. Vivek Reddy

Lariat Trials Update – Dr. Randall Lee

Amplatzer Cardiac Plug Trials Update – Dr. Apostolos Tzikas

AtriClip and Other Surgical Tools – Dr. Basel Ramlawi

Panel Discussion

Session 11 Oral Anticoagulants in 2016

Relevance of Coumadin and Coumadin isomers for Stroke Prophylaxis in 2016 – Dr. David Wilber

Updates on the NOAC Quartet – Dabigatran, Rivaroxaban, Apixiban and Edoxaban – Dr. Larry Chinitz

How do you Choose Which NOAC for Whom? Clinical Decision Path for a Clinician – Dr. Luigi Di Biase

Oral Anticoagulation Reversal in Warfarin and NOACs – Dr. Samuel Asirvatham

Is LAA Exclusion a Substitute for Warfarin Ineligible Patients?  – Dr. Andrea Natale

Role of Octreotide Therapy for Microvascular Gut Bleeding on OAC – Emerging Data – Dr. Dhanunjaya Lakkireddy

Panel Discussion

Session 12 Practical Issues in Stroke Prophylaxis

LAA exclusion is a Better Strategy for Stroke Prophylaxis Than Oral Anticoagulation in AF Patients – Debate – Dr. Samuel Asirvatham and Dr. Horst Sievert

How to Build a Successful LAA Referral Program – Dr. Srinivas Dukkipati

Navigating the Regulatory and Reimbursement Issues in LAA Technologies and NOACs – Dr. Brian Whisenent

Multi-disciplinary Approach in LAA Exclusion – Aligning the Strengths of an IC, EP, Imager and CT Surgeon – Dr. Vijay Swarup

LAA Exclusion in Warfarin Ineligible patients – How to Design the Perfect Trial – Dr. David Wilber

Panel Discussion

Session 13 Future of LAA Exclusion and NOACs

 – Dr. Saibal Kar, Dr. Vivek Reddy, Dr. Andrea Natale, Dr. David R. Holmes Jr., Dr. James Edgerton


Copyright © ISLAA-KC. All Rights Reserved. Privacy Policy
Site Created by KC Web Specialists, LLC.